Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pfizer (NY: PFE )

28.14 +0.37 (+1.31%)
Streaming Delayed Price Updated: 1:08 PM EDT, May 8, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 18,660,948
Open 27.70
Bid (Size) 28.13 (51)
Ask (Size) 28.14 (94)
Prev. Close 27.77
Today's Range 27.52 - 28.29
52wk Range 25.20 - 40.37
Shares Outstanding 5,606,688,356
Dividend Yield 5.83%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Just Say No to Drugs: 3 Pharma Stocks to Avoid
Discover which pharma stocks to avoid in 2023 as we delve into market trends, financial struggles, and the impact on investor portfolios. 
Via InvestorPlace
Mitigating Muscle Loss Becoming More Vital, Global Cancer Cachexia Market Projected to Reach $3.3 Billion in 2024
EQNX::TICKER_START (OTCPK:MUSLF),(CSE:MUSL),(NYSE:MRK),(NYSE:PFE),(NASDAQ:MRNA),(NASDAQ:AZN) EQNX::TICKER_END 
Via FinancialNewsMedia

Performance

YTD
-5.36%
-5.36%
1 Month
+5.85%
+5.85%
3 Month
+2.31%
+2.31%
6 Month
-9.97%
-9.97%
1 Year
-27.24%
-27.24%

More News

Read More
Got $1,000? 3 Dividend Stocks to Buy and Hold Forever
Via The Motley Fool
Pfizer's Options Frenzy: What You Need to Know
Via Benzinga
Pfizer Unusual Options Activity
Via Benzinga
Mitigating Muscle Loss Becoming More Vital, Global Cancer Cachexia Market Projected to Reach $3.3 Billion in 2024
From FN Media Group LLC
Via GlobeNewswire
Jim Cramer Advises Investors To Brace For Economic Slowdown, Shares Tips To Maintain Balanced Portfolio: 'I'm Not Telling You To Relax'
Via Benzinga
Topics Economy
Exposures Economy
A Look At Pharma ETFs Post Q1 Earnings
Via Talk Markets
Topics ETFs
Biotech Breakthroughs: 7 Stocks Driving the Next Wave in Healthcare
Via InvestorPlace
Tuesday Talk: Still Flying
Via Talk Markets
Maximize Your Dividends: 7 Stocks Trading Under $50 with 5%+ Yields
Via InvestorPlace
What's Going With BioNTech Stock On Monday?
Via Benzinga
Pfizer Announces New Chief Strategy and Innovation Officer
From Pfizer Inc.
Via Business Wire
Pfizer Finds a Foothold After a Solid Q1 2024 Earnings Report
Via MarketBeat
Exposures COVID-19
How this baseball All-Star steps up to the plate when it comes to pneumococcal pneumonia
Via Brandpoint
Revive Your Portfolio: 3 Undervalued Stocks Poised for Growth
Via InvestorPlace
3 No-Brainer Stocks to Buy in May
Via The Motley Fool
Can Pfizer Challenge Lilly and Novo Nordisk in the Obesity Market?
Via The Motley Fool
3 High-Yield Dividend Stocks to Buy Now and Hold at Least a Decade
Via The Motley Fool
Stock Market Rallies On Fed, Jobs Report, Apple: Weekly Review
Via Investor's Business Daily
Topics Economy
Exposures Interest Rates
3 Ultra-Safe Stocks to Buy So You Can Rest Easy in Any Market
Via InvestorPlace
Pfizer Prospects Garner Mixed Sentiment From Analysts: 'Finally, The Pivot Investors Have Been Waiting For'
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
3 Contrarian Stocks That Could Make You a Fortune (If You Dare)
Via InvestorPlace
Moderna Puts Up Big Quarterly Beat; Could Shares Notch A Breakout?
Via Investor's Business Daily
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.